Acadia Pharmaceuticals (ACAD) EBITDA Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded EBITDA Margin of 13.31% in Q2 2026, down 0.03 percentage points from 13.35% a year earlier but up 13.92 percentage points from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EBITDA Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Acadia Pharmaceuticals' EBITDA Margin came in at 8.64% as of Jun 30, 2026, down 15.94 percentage points year-over-year; for FY2025, it was 10.88%, down 14.87 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +75.08 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 25.75% in FY2024 (+35.09 pp), -9.33% in FY2023 (+33.51 pp), -42.84% in FY2022 (-8.32 pp) and -34.51% in FY2021 (+29.68 pp).
- Quarterly EBITDA Margin has ranged from -97.43% in Q1 2022 to 61.14% in Q4 2024 over the past five years.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of +2.58 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 59.77 percentage points in Q3 2021, against a drop of 53.97 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -0.61% (Q1 2026), 7.16% (Q4 2025) and 13.89% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 39.16% |
| 10 | Acadia Pharmaceuticals | 3.49 Bn | 19.20 Mn | 279.64 Mn | 13.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.31% |
| Mar 31, 2026 | -0.61% |
| Dec 31, 2025 | 7.16% |
| Sep 30, 2025 | 13.89% |
| Jun 30, 2025 | 13.35% |
| Mar 31, 2025 | 9.10% |
| Dec 31, 2024 | 61.14% |
| Sep 30, 2024 | 13.66% |
| Jun 30, 2024 | 13.64% |
| Mar 31, 2024 | 10.08% |
| Dec 31, 2023 | 15.85% |
| Sep 30, 2023 | -26.48% |
| Jun 30, 2023 | 2.91% |
| Mar 31, 2023 | -44.87% |
| Dec 31, 2022 | -33.39% |
| Sep 30, 2022 | -23.23% |
| Jun 30, 2022 | -24.62% |
| Mar 31, 2022 | -97.43% |
| Dec 31, 2021 | -33.74% |
| Sep 30, 2021 | -10.85% |
API Access
Acadia Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();